Search Khaleej Dailies

Friday, January 23, 2026

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing


 (BUSINESS WIRE) -- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies.


Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of year 2025 on Form 6-K.


As disclosed on January 4, 2026, the Company has engaged Zhonghua Certified Public Accountants LLP (“Zhonghua”) as its independent registered public accounting firm. SINOVAC is working diligently with Zhonghua to complete the required audit and to regain compliance with its filing obligations by May 11, 2026.


The Company remains committed to completing the requisite audit procedures and regulatory filings as expeditiously as practicable and to maintaining compliance with applicable U.S. Securities and Exchange Commission and Nasdaq requirements.


Safe Harbor Statement


This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.


About SINOVAC


Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of "supply vaccines to eliminate human diseases", the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.


The company's diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.


SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world's first inactivated SARS vaccine (Phase I completed), China's first H5N1 influenza vaccine (Panflu®), the world's first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.


Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.


With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.


For more information, please see the Company’s website at www.sinovac.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260122376718/en/



Permalink

https://www.aetoswire.com/en/news/2201202652564


Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

Illumynt تعيّن Chris Tejeda رئيسًا تنفيذيًا للإيرادات

 


 بوسطن - الخميس, 22. يناير 2026 


(BUSINESS WIRE)-- أعلنت illumynt اليوم عن ترقية Chris Tejeda إلى منصب الرئيس التنفيذي للإيرادات (CRO)، في خطوة تعكس النمو المستمر للشركة وتوسّع حضورها العالمي.

في منصبه الجديد، سيتولى Tejeda قيادة استراتيجية الإيرادات العالمية لشركة Illumynt، وتعزيز تفاعل العملاء، وبناء الشراكات الاستراتيجية، تزامنًا مع تزايد الطلب على حلول إدارة الأصول التقنية (ITAD) الآمنة والمعتمدة على التكنولوجيا.

قال Joerg Herbarth، الرئيس التنفيذي للشركة: "لعب كريس دورًا محوريًا في مواءمة استراتيجيتنا التجارية مع الاحتياجات المتطورة للعملاء من شركات واسعة النطاق والمؤسسات الكبرى". "ومع تسارع وتيرة تحديث البنية التحتية بفعل الذكاء الاصطناعي وارتفاع معايير الأمن والامتثال، ستشكل قيادته عنصرًا حاسمًا في توسيع نطاق Illumynt بطريقة مركزة، شفافة، ومبنية على ثقة العملاء".

يتمتّع Tejeda بخبرة واسعة في خدمات تقنيات المؤسسات، ولعب دورًا محوريًا في زخم Illumynt الأخير، بما في ذلك تحقيق نمو ملحوظ في الإيرادات وتوسيع القدرات المتقدمة في مجالات تشخيص الذكاء الاصطناعي ووحدات معالجة الرسوميات (GPU)، والأتمتة، واسترداد القيمة.

إن نص اللغة الأصلية لهذا البيان هو النسخة الرسمية المعتمدة. أما الترجمة فقد قدمت للمساعدة فقط، ويجب الرجوع لنص اللغة الأصلية الذي يمثل النسخة الوحيدة ذات التأثير القانوني.


الرابط الثابت
https://www.aetoswire.com/ar/news/2201202652521

جهات الاتصال
Alyson Kaye
 617.407.6381



illumynt Appoints Chris Tejeda as Chief Revenue Officer

 BOSTON - Wednesday, 21. January 2026


(BUSINESS WIRE) -- illumynt today announced the promotion of Chris Tejeda to Chief Revenue Officer (CRO), reflecting the company’s continued growth and expanding global footprint.

In his new role, Tejeda will lead illumynt’s global revenue strategy, customer engagement, and strategic partnerships as demand accelerates for secure, technology-driven IT Asset Disposition (ITAD) solutions.

“Chris has been instrumental in aligning our commercial strategy with the evolving needs of hyperscale and enterprise customers,” said CEO Joerg Herbarth. “As AI accelerates infrastructure refresh cycles and raises the bar for security and compliance, his leadership will be critical to scaling illumynt with focus, transparency, and customer trust.”

Tejeda brings extensive experience in enterprise technology services and has played a key role in illumynt’s recent momentum, including significant revenue growth and the expansion of advanced capabilities across AI/GPU diagnostics, automation, and value recovery.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121903784/en/


Permalink
https://www.aetoswire.com/en/news/2101202652490

Contacts
Alyson Kaye
617.407.6381

Programme de recherche des Émirats arabes unis pour l'amélioration des précipitations : lauréats des subventions du 6e cycle


 Abou Dabi, Émirats arabes unis - jeudi, 22. janvier 2026 AETOSWire Print 



Le Programme de recherche des Émirats arabes unis pour l'amélioration des précipitations (UAEREP), géré par le Centre national de météorologie (NCM), a annoncé les lauréats de ses subventions de recherche du sixième cycle. Chaque lauréat recevra jusqu'à 1,5 million de dollars américains sur trois ans, avec une allocation annuelle maximale de 550 000 dollars américains.


Les lauréats du sixième cycle sont : le Dr Dixon Michael, météorologue radar principal et ingénieur logiciel chez Echo Science Works (États-Unis), pour ses travaux intitulés « Faire progresser la science de l'ensemencement des nuages ​​grâce aux signatures radar à double polarisation et à l'intelligence artificielle » ;  la professeure Linda Zou, professeure associée à l'Université Victoria (Australie), pour ses travaux intitulés « Développement et optimisation assistés par l'IA de matériaux d'ensemencement des nuages ​​glaciogènes » ; et le Dr Oliver Branch, chercheur principal à l'Université de Hohenheim, en Allemagne, pour « Amélioration des précipitations par la modification de la couverture terrestre et de la forme du terrain (RAINLAND) ».


Son Excellence le Dr Abdulla Al Mandous, Président de l'Organisation météorologique mondiale et Directeur général du NCM, a déclaré : « Sous l'égide de Son Altesse Cheikh Mansour bin Zayed Al Nahyan, Vice-Président, Vice-Premier Ministre et Président de la Cour présidentielle, l'UAEREP continue de consolider sa position de plateforme mondiale de collaboration scientifique et d'innovation appliquée. Le NCM joue un rôle central dans la réalisation de ces travaux grâce à des infrastructures de pointe et une expertise opérationnelle qui permettent de traduire la recherche en actions concrètes. Ceci illustre la volonté des Émirats arabes unis d'investir dans une innovation pratique et durable. »


Alya Al Mazrouei, Directrice de l'UAEREP et Directrice du Département de la recherche et de l'amélioration des conditions météorologiques du NCM, a déclaré : « Les propositions des lauréats témoignent d'un haut niveau d'innovation scientifique et d'application pratique. Grâce aux ressources techniques de l'UAEREP et à ses collaborations internationales, ces projets apporteront des solutions scientifiques contribuant à la sécurité hydrique et à la résilience climatique. »


Le projet du Dr Dixon Michael vise à faire progresser l'évaluation des impacts de l'ensemencement des nuages ​​au-delà du suivi traditionnel des orages basé sur la réflectivité. Il modernisera LROSE/TITAN afin de saisir les mécanismes microphysiques et d'évaluer les impacts à l'aide de méthodes transparentes et tenant compte des incertitudes, tout en renforçant la capacité du NCM à maintenir ces systèmes.


Le projet de la professeure Linda Zou développera des matériaux nanocomposites avancés pour la nucléation de la glace et appliquera des analyses pilotées par l'IA afin d'optimiser leurs performances à partir des données d'une chambre à brouillard PINE (Portable Ice Nucleation Experiment), qui sera déployée au NCM lors de la phase finale du projet.


Le projet RAINLAND du Dr Oliver Branch appliquera une approche théorie-observation-simulation pour démontrer comment les modifications de la couverture terrestre et de la topographie peuvent déclencher la convection humide. La recherche vise à identifier les configurations et les emplacements optimaux du relief pour accroître les précipitations aux Émirats arabes unis.



Permalink

https://www.aetoswire.com/fr/news/2201202652548


Contacts

Salam Shehady


sshehady@apcoworldwide.comAbou Dabi, Émirats arabes unis - jeudi, 22. janvier 2026 AETOSWire Print 



Le Programme de recherche des Émirats arabes unis pour l'amélioration des précipitations (UAEREP), géré par le Centre national de météorologie (NCM), a annoncé les lauréats de ses subventions de recherche du sixième cycle. Chaque lauréat recevra jusqu'à 1,5 million de dollars américains sur trois ans, avec une allocation annuelle maximale de 550 000 dollars américains.


Les lauréats du sixième cycle sont : le Dr Dixon Michael, météorologue radar principal et ingénieur logiciel chez Echo Science Works (États-Unis), pour ses travaux intitulés « Faire progresser la science de l'ensemencement des nuages ​​grâce aux signatures radar à double polarisation et à l'intelligence artificielle » ;  la professeure Linda Zou, professeure associée à l'Université Victoria (Australie), pour ses travaux intitulés « Développement et optimisation assistés par l'IA de matériaux d'ensemencement des nuages ​​glaciogènes » ; et le Dr Oliver Branch, chercheur principal à l'Université de Hohenheim, en Allemagne, pour « Amélioration des précipitations par la modification de la couverture terrestre et de la forme du terrain (RAINLAND) ».


Son Excellence le Dr Abdulla Al Mandous, Président de l'Organisation météorologique mondiale et Directeur général du NCM, a déclaré : « Sous l'égide de Son Altesse Cheikh Mansour bin Zayed Al Nahyan, Vice-Président, Vice-Premier Ministre et Président de la Cour présidentielle, l'UAEREP continue de consolider sa position de plateforme mondiale de collaboration scientifique et d'innovation appliquée. Le NCM joue un rôle central dans la réalisation de ces travaux grâce à des infrastructures de pointe et une expertise opérationnelle qui permettent de traduire la recherche en actions concrètes. Ceci illustre la volonté des Émirats arabes unis d'investir dans une innovation pratique et durable. »


Alya Al Mazrouei, Directrice de l'UAEREP et Directrice du Département de la recherche et de l'amélioration des conditions météorologiques du NCM, a déclaré : « Les propositions des lauréats témoignent d'un haut niveau d'innovation scientifique et d'application pratique. Grâce aux ressources techniques de l'UAEREP et à ses collaborations internationales, ces projets apporteront des solutions scientifiques contribuant à la sécurité hydrique et à la résilience climatique. »


Le projet du Dr Dixon Michael vise à faire progresser l'évaluation des impacts de l'ensemencement des nuages ​​au-delà du suivi traditionnel des orages basé sur la réflectivité. Il modernisera LROSE/TITAN afin de saisir les mécanismes microphysiques et d'évaluer les impacts à l'aide de méthodes transparentes et tenant compte des incertitudes, tout en renforçant la capacité du NCM à maintenir ces systèmes.


Le projet de la professeure Linda Zou développera des matériaux nanocomposites avancés pour la nucléation de la glace et appliquera des analyses pilotées par l'IA afin d'optimiser leurs performances à partir des données d'une chambre à brouillard PINE (Portable Ice Nucleation Experiment), qui sera déployée au NCM lors de la phase finale du projet.


Le projet RAINLAND du Dr Oliver Branch appliquera une approche théorie-observation-simulation pour démontrer comment les modifications de la couverture terrestre et de la topographie peuvent déclencher la convection humide. La recherche vise à identifier les configurations et les emplacements optimaux du relief pour accroître les précipitations aux Émirats arabes unis.



Permalink

https://www.aetoswire.com/fr/news/2201202652548


Contacts

Salam Shehady


sshehady@apcoworldwide.com

شركة Sisvel تطلق مجموعة براءات اختراع Wi-Fi Multimode

  لوكسمبورج - الخميس, 22. يناير 2026 أيتوس واير



 أنشأ عشرة من مالكي براءات الاختراع حل ترخيص يغطي معايير Wi‑Fi 6 وWi‑Fi 7


(BUSINESS WIRE)-- أطلقت شركة Sisvel مجموعة براءات اختراع Wi-Fi Multimode رائدة، تيسر سبل الوصول إلى البراءات الأساسية للمعايير المملوكة لعشر شركات رائدة في تكنولوجيا Wi‑Fi 6 وWi‑Fi 7.


يأتي هذا البرنامج الجديد استكمالاً لمسيرة مجموعة براءات اختراع Wi-Fi 6 الناجحة للغاية من Sisvel، والتي نجحت على مدار ثلاثة أعوام في إبرام اتفاقيات مع نحو 40 شركة، من ضمنها Acer وNetgear وCisco وHP، ليقدم طريقة فعالة للحصول على حقوق Wi-Fi الأساسية لأعوام قادمة.


تضم قائمة أصحاب البراءات العشرة المؤسسون ضمن برنامج Wi-Fi Multimode‏، شركة Huawei وKPN وMitsubishi Electric وOrange وPanasonic وPhilips وAegis 11 SA (شركة تابعة لشركة Sisvel) وSK Telecom وWilus وZTE.


بالإضافة إلى ذلك، حصلت شركة Sony Group Corporation على ترخيص ضمن برنامج Wi-Fi Multimode. كما تؤكد هذه الاتفاقية المبكرة مع شركة رائدة ومعروفة عالميًا في مجال Wi‑Fi القيمة الكبيرة لمجموعة البراءات والجهود التي بذلتها Sisvel للتواصل مع كل أطراف السوق في أثناء تأسيس المجموعة.


تم تعيين Giorgia Varvelli مديرة لبرنامج Wi‑Fi Multimode؛ إذ كانت تشغل سابقًا نفس المنصب في مجموعة براءات Wi‑Fi 6، ولعبت دورًا أساسيًا في نجاحها.


صرح Mattia Fogliacco، الرئيس والمدير التنفيذي لشركة Sisvel، قائلاً: "يمثل إعلان اليوم علامة فارقة في رحلة ترخيص تقنيات Wi‑Fi". "لقد جعلنا الوصول إلى الحقوق الأساسية لتقنيات Wi‑Fi عبر عدة أجيال أمرًا بسيطًا وسهلاً من خلال عملية تعاقدية واحدة. وإنني أود أن أشير إلى أنَّ هذا ثمرة أعوام من العمل الجاد لفريق Sisvel وكل شركائنا. لذا، فنحن نتطلع إلى تأكيد ثقة السوق بنا عن طريق إدارة هذا البرنامج الحيوي لترخيص البراءات بفعالية".


أضافت Varvelli، قائلة: "يحدوني بالغ الحماس إزاء التعاون مع الجهات المانحة لترخيص Wi‑Fi 6 السابقة ومع أصحاب البراءات الجدد الذين انضموا إلى البرنامج". "بفضل هذا البرنامج، نستمر في إرسال رسالة قوية إلى السوق مفادها: الابتكارات في مجال Wi‑Fi لها قيمة، وثمة طريقة شفافة وفعّالة لترخيص الحقوق الأساسية، وهذا من شأنه دفع عجلة البحث والتطوير وتعزيز إطلاق المزيد من الاختراعات وتطوير تقنيات أكثر تقدمًا. وبالتعاون مع شركة Sony، إحدى الشركات الرائدة عالميًا في تطبيق تقنيات Wi-Fi، سنتمكن من بناء بيئة ترخيص Wi‑Fi تدعم الابتكار".


 تفضل بزيارة https://www.wifipatentpool.com لمزيد من المعلومات.


 نبذة عن Sisvel


ينبع نجاح Sisvel من إيمانها بأهمية التعاون والإبداع والكفاءة اللازمين لتلبية احتياجات أصحاب براءات الاختراع وأولئك الذين يرغبون في الاستفادة من تقنياتهم. وفي غمار سوق معقدة يطولها تطور مستمر، يتمثل المبدأ التوجيهي في توفير فرص متكافئة عن طريق تطوير وتنفيذ حلول تسويقية مرنة وسهلة المنال.


Sisvel | دعم الابتكار رسالتنا


إن نص اللغة الأصلية لهذا البيان هو النسخة الرسمية المعتمدة. أما الترجمة فقد قدمت للمساعدة فقط، ويجب الرجوع لنص اللغة الأصلية الذي يمثل النسخة الوحيدة ذات التأثير القانوني.



الرابط الثابت

https://www.aetoswire.com/ar/news/2201202652563


جهات الاتصال

 المسؤول الإعلامي

 Giulia Dini

 رئيس قسم الاتصالات

 الهاتف: ‎+34 93 131 5570

 giulia.dini@sisvel.com

WGS 2026 : un rassemblement planétaire inédit pour façonner les gouvernements de demain

 Le WGS 2026 organise le Forum d’investissement de haut niveau Amérique latine–Caraïbes et lance en première mondiale : le Sommet des Lauréats


 



L’édition 2026 du Sommet mondial des gouvernements (World Governments Summit – WGS) s’apprête à accueillir la plus vaste participation internationale depuis sa création. Cette édition d’envergure réunira plusieurs forums emblématiques, confirmant le statut du Sommet comme plateforme pionnière à l’échelle mondiale.


Le forum rassemblera un large éventail de grandes entreprises internationales et d’institutions de référence, parmi lesquelles le Fonds monétaire international (FMI), la Société financière internationale (IFC), membre du Groupe de la Banque mondiale, ainsi qu’un nombre record de plus de 35 chefs d’État, des délégations officielles de haut niveau et des représentants de plus de 150 gouvernements.


Le WGS 2026 accueillera également une série de forums internationaux de premier ordre, dont le Forum de la Nouvelle Route de la Soie, le Forum d’investissement de haut niveau piloté par l’IFC consacré à l’Amérique latine et aux Caraïbes, la 10ᵉ Conférence internationale de coopération organisée en collaboration avec l’Association des États de la Caraïbe, ainsi que le Forum sur l’avenir de l’économie, consacré aux transformations économiques mondiales et aux modèles de croissance durable.


Marquant également sa première mondiale en dehors de Shanghai, en Chine, le Sommet des Lauréats du Monde (World Laureates Summit – WLS) réunira des lauréats du prix Nobel, du prix Turing, de la médaille Fields, de l’initiative Great Arab Minds, ainsi que des personnalités scientifiques internationales de premier plan. Prévu du 3 au 5 février, cet événement — le plus important de son genre — organisé en collaboration avec la World Laureates Association, rassemblera des lauréats et des dirigeants mondiaux afin d’élaborer des solutions fondées sur la science pour répondre aux défis mondiaux les plus pressants.


Parmi les personnalités de premier plan dont la participation est confirmée figurent Michael Levitt (prix Nobel de chimie 2013), Kip Thorne (prix Nobel de physique 2017) et John Hopcroft (prix Turing 1986).


Les résultats et recommandations issus du Sommet des Lauréats du Monde seront annoncés lors du Sommet mondial des gouvernements – WGS 2026.


Le Sommet mondial des gouvernements 2026 se tiendra du 3 au 5 février sous le thème « Façonner les gouvernements de demain », et enregistrera la plus forte participation internationale de toute son histoire.


Fort de plus de 320 sessions, le Sommet accueillera plus de 100 organisations internationales et régionales ainsi que plus de 450 personnalités de premier plan à l’échelle mondiale, parmi lesquelles des présidents, des ministres, des experts, des leaders d’opinion et des décideurs.


Le programme du Sommet mondial des gouvernements 2026 comprendra 24 forums mondiaux spécialisés, consacrés à l’anticipation des tendances futures dans des secteurs stratégiques et essentiels.


La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.



Permalink

https://www.aetoswire.com/fr/news/wgs2312026f


Contacts

Ahmed Yahya


ayahya@apcoworldwide.com

Sisvel Launches Wi-Fi Multimode Patent Pool

  LUXEMBOURG - Thursday, 22. January 2026 AETOSWire 



Ten patent owners establish licensing solution covering Wi-Fi 6 and Wi-Fi 7 standards


(BUSINESS WIRE) -- Sisvel has launched a groundbreaking Wi-Fi Multimode patent pool offering access to standard essential patents owned by 10 Wi-Fi 6 and Wi-Fi 7 technology leaders.


As the successor to Sisvel’s highly successful Wi-Fi 6 patent pool – which, over a three-year period, closed agreements with nearly 40 companies, including Acer, Netgear, Cisco and HP – the new programme offers an efficient way to access essential Wi-Fi rights for years to come.


The 10 founding patent owners in the Wi-Fi Multimode programme are Huawei, KPN, Mitsubishi Electric, Orange, Panasonic, Philips, Aegis 11 SA (a Sisvel affiliate), SK Telecom, Wilus and ZTE.


In addition, Sony Group Corporation has taken a licence under the Wi-Fi Multimode programme. This early agreement with a sophisticated and globally recognised Wi-Fi leader and implementer underlines the pool’s strong value proposition and the efforts made by Sisvel to engage with all parts of the market during pool formation.


Giorgia Varvelli has been named Wi-Fi Multimode programme manager; she previously held the same role for the Wi-Fi 6 patent pool, playing an instrumental role in its success.


“Today’s announcement is a milestone for Wi-Fi licensing,” says Sisvel President and CEO Mattia Fogliacco. “We have made it simple and straightforward to access essential rights across multiple Wi-Fi generations in a single transaction. This is the product of years of hard work by the Sisvel team and all our partners. We look forward to repaying the market’s trust in us to manage this critically important licensing programme.”


“It is exciting to be working with our returning Wi-Fi 6 licensors and the new patent owners that have come on board,” adds Varvelli. “With this programme, we continue to send a strong signal to the market: Wi-Fi innovation has value; and there is a transparent, efficient way to license essential rights. This will drive more R&D, more invention and more advanced technologies. Together with leading Wi-Fi implementers Sony, we are building a Wi-Fi licensing environment that powers innovation.”


Visit https://www.wifipatentpool.com for more information.


About Sisvel


Sisvel is driven by a belief in the importance of collaboration, ingenuity and efficiency to bridge the needs of patent owners and those who wish to access their technologies. In a complex and constantly evolving marketplace, our guiding principle is to create a level playing field with the development and implementation of flexible, accessible, commercialisation solutions.


Sisvel | We Power Innovation


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260122892826/en/



Permalink

https://www.aetoswire.com/en/news/2201202652562


Contacts

Media Contact

Giulia Dini

Head of Communications

Tel: +34 93 131 5570

giulia.dini@sisvel.com

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis


 New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights


(BUSINESS WIRE) -- Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker™. The new functionality complements Parse’s existing portfolio of Evercode immune products to enable a full end-to-end workflow for researchers.


Immunologists have lacked an integrated, purpose-built platform capable of connecting immune repertoire data with whole transcriptome single cell insights. As a result, interpreting clonal behavior, understanding functional cell states, and drawing meaningful biological conclusions has often required stitching together fragmented tools, custom code, or inconsistent visualization approaches. The new Trailmaker functionality directly addresses these challenges by providing an accessible, end-to-end immune profiling solution that brings repertoire and transcriptional information together in a cohesive environment.


The new functionality combines immune repertoire and whole transcriptome data to give researchers a complete view of clonal structure, diversity, and antigen-driven signatures. Users can visualize clonotypes and cell types on an integrated UMAP, quickly identify dominant clones with frequency and honeycomb plots, and use unique motif analysis to detect conserved patterns. By linking repertoire data with full transcriptome expression, Trailmaker makes it easy to connect clonotypes to their transcriptional states, reveal clonotype-specific gene programs, and run targeted differential expression, delivering deeper, more contextualized biological insights.


“Our goal has always been to remove barriers for researchers,“ says Charlie Roco, PhD, Co-founder and Chief Technology Officer at Parse. “By making immune profiling intuitive and more fully integrated, we’re empowering immunologists to spend less time wrangling the data and more time assigning biological significance.”


To learn more, attend the company’s upcoming educational webinar on January 29 at 8:00 AM Pacific Time: https://parse.bio/45bmrJT.


About Parse Biosciences


Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260122181379/en/



Permalink

https://aetoswire.com/en/news/2201202652571


Contacts

Kaitie Kramer

kkramer@parsebiosciences.com | 858.504.0455

Open World Launches Saudi Arabia’s First RWA Tokenization Center of Excellence to Advance Vision 2030 Digital Economy Goals

In-Kingdom operating entity to enable compliant digital asset innovation for sovereign and enterprise-scale initiatives under Saudi regulatory frameworks

 

(BUSINESS WIRE)--Open World Ltd. (“Open World”), a blockchain infrastructure company with experience supporting large-scale digital asset initiatives, today announced the establishment of Saudi Arabia’s first RWA (Real-World Asset) Tokenization Center of Excellence. The news follows Open World’s announcement on January 5, 2026, regarding its plans to merge with VerifyMe, Inc. (NASDAQ: VRME) (“VerifyMe”), positioning the combined entity for participation in public markets as a leading infrastructure provider in the digital asset and tokenization sector.

The RWA Center of Excellence will operate as a fully licensed and, as regulations are defined, in-Kingdom entity designed to accelerate compliant digital asset innovation for sovereign, enterprise, and institutional clients across Saudi Arabia and the broader Middle East. The initiative will directly support the Kingdom’s Vision 2030 Financial Sector Development Program, which seeks to establish Saudi Arabia as a globally competitive financial and investment hub.

As the Saudi regulatory frameworks continue to mature, the Center of Excellence will enable compliant tokenization of real-world assets, including energy infrastructure, tokenized carbon reduction credits, real estate, sovereign bonds and, over time, regulated stablecoins. These initiatives will be launched on Open World’s sovereign and national-scale tokenization infrastructure introduced in December 2025 through its partnership with Abstract. This will provide Saudi enterprises and government entities new pathways to access global capital markets while maintaining full regulatory compliance with Saudi Central Bank (SAMA) and Capital Market Authority (CMA) requirements.

“Saudi Arabia is leading the global conversation on how digital assets can be deployed in service of national economic priorities,” said Matt Shaw, co-founder and CEO of Open World. “By establishing our Center of Excellence in Al Khobar, we are making a long-term commitment to build alongside Saudi partners, under Saudi regulations, with infrastructure that meets the Kingdom’s sovereign data and security requirements. Our goal is to help transform Saudi Arabia’s tremendous real-world asset base into globally accessible, compliant digital instruments that attract international investment while ensuring value creation remains within the Kingdom.”

Initial focus areas for the Center of Excellence include certain types of energy asset tokenization, real estate development financing, and the on-chain verification and storage of carbon reduction credits. The Center has been structured to meet sovereign-grade delivery standards, with a strong emphasis on data residency, local security controls and national economic considerations aligned with the Kingdom’s localization objectives.

“Welcoming Open World to Al Khobar represents a significant step in our region’s digital transformation journey,” said Dr. Salman Salem Al Khaldi, member of the Industry and Energy Committee at the Eastern Province Chamber of Commerce and Industry. “The Eastern Province is home to Saudi Aramco, King Fahd University of Petroleum and Minerals, Dhahran Techno Valley and the Kingdom’s largest concentration of energy assets, making it the ideal location to pioneer real-world asset tokenization. This initiative aligns perfectly with Vision 2030’s goal to develop our financial sector and diversify our economy beyond traditional energy exports.”

The RWA Center of Excellence is expected to commence full operations in 2026, with initial pilot projects targeted for mid-year launch. Open World has established the necessary legal, licensing, commercial and technological infrastructure required to operate directly within Saudi Arabia’s regulatory environment.

To support growing institutional adoption in Saudi Arabia, Open World said it plans to work with financial institutions, government entities and regulators to develop frameworks for investor protection, regulatory clarity and standardized tokenization practices, with strategic partnership announcements expected throughout 2026.

About Open World Ltd.
Open World has been a major driving force behind many of the most iconic projects in blockchain. Given its expertise, Open World is now expanding its offerings to traditional finance (TradFi). Open World has facilitated the inception and growth of more than 20 companies since 2023 and has helped launch over $65 billion in aggregate network value since (at peak FDV). Open World advises founding teams as they navigate the most complex intersections of financial regulatory, tokenomics, public markets, exchange strategy and governance structuring. The teams Open World advises are partners with leading venture capital firms, including a16z, Multicoin Capital, Dragonfly and Founders Fund. The firm’s range of services includes token launch advisory, DATs and TradFi strategies, RWA tokenization, stablecoin issuance, policy advocacy and strategic advisory work. To learn more, visit https://www.openworld.dev.

About VerifyMe, Inc.
VerifyMe provides specialized logistics for time and temperature-sensitive products, as well as brand protection and enhancement solutions. To learn more, visit https://www.verifyme.com/.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “become,” “expected,” “plans,” “upon,” “will,” and similar expressions, as they relate to Open World and VerifyMe, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the uncertainty of whether Open World and VerifyMe will enter into a merger agreement and, if they do enter into a merger agreement, that the merger will close. Additionally, the expected benefits of the merger may not be realized. These risk factors and uncertainties include those more fully described in VerifyMe’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission (“SEC”), including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Additional Information About the Proposed Transaction and Where to Find It
This document includes discussion related to a proposed transaction between Open World and VerifyMe. In connection with the proposed transaction, if the parties enter into a merger agreement, VerifyMe intends to file a proxy statement, and, if required by the definitive merger agreement, a registration statement on Form S-4 with the SEC relating to the proposed transaction. After concluding the SEC comment process, and, if applicable, the registration statement is declared effective, VerifyMe will mail a definitive proxy statement, and, if applicable, a prospectus, to its stockholders. VerifyMe will also file other documents regarding the proposed transaction with the SEC.

Investors and securityholders are urged to read the proxy statement and any prospectus, and other relevant documents filed with the SEC carefully when they become available, because they will contain important information about Open World, VerifyMe, and the proposed transaction.

Copies of the proxy statement and any prospectus and all other relevant documents filed or that will be filed with the SEC by VerifyMe will be available free of charge on the SEC’s website at https://www.sec.gov and on VerifyMe’s website at https://vrmeinvestor.com/ or by written request to VerifyMe at VerifyMe, Inc., Attn: Corporate Secretary, 801 International Parkway, Fifth Floor, Lake Mary, Florida 32746.

Participants in the Solicitation
Open World and VerifyMe and their respective directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies from VerifyMe’s stockholders in connection with the proposed merger. If the parties enter into a merger agreement, a list of the names of the directors and executive officers of VerifyMe and information regarding their interest in the proposed merger will be contained in the proxy statement and any prospectus when available. Additional information regarding the interests of the persons who may, under SEC rules, be deemed participants in the solicitation of proxies of VerifyMe’s stockholders in connection with the proposed merger, including the names and interests of Open World’s directors and executive officers, will be set forth in the proxy statement and any prospectus for the proposed merger, which is expected to be filed by Open World and VerifyMe with the SEC after the parties enter into a merger agreement.

No Offer or Solicitation
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under applicable securities laws.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260122106738/en/



Contacts

Media
Company: Open World Ltd.
Email: openworld@wachsman.com

Company: VerifyMe, Inc.
Email: IR@verifyme.com


شركة I Squared تعلن عن إطلاق Radiant Energy Solutions


(BUSINESS WIRE)-- أعلنت اليوم شركة I Squared Capital (I Squared)، الرائدة عالميًا في إدارة استثمارات البنية التحتية، عن إطلاق Radiant Energy Solutions (Radiant). يأتي هذا الاستثمار ضمن إستراتيجية I Squared للبنية التحتية في الشرق الأوسط، والتي تركز على استهداف استثمارات تحويلية في فئة السوق المتوسطة داخل المنطقة.


انطلاقًا من نهج I Squared المتبع في بناء المنصات، والذي يبدأ باستثمار أساسي أولي ثم التوسع تدريجيًا بمرور الوقت لبناء شركات رائدة في السوق، تمثل Radiant بوابة دخول الشركة إلى سوق الطاقة المتجددة الموزعة في الشرق الأوسط، حيث تقدم حلول إزالة الكربون لعملاء القطاعين التجاري والصناعي. أما الاستثمار تحت مظلة Radiant، فإنه يأتي في صورة صفقة الاستحواذ على FAS Renewables وشركتها التابعة المملوكة بالكامل Zahra Energy، وهي شركة متخصصة في الطاقة الشمسية الموزعة مقرها المملكة العربية السعودية، وتمتلك محفظة مشروعات طاقة شمسية موزعة آمنة ومتقدمة تزيد قدرتها على 100 ميجاواط ذروة (MWp)، مع قاعدة عملاء راسخة واتفاقيات شراء طاقة شمسية طويلة الأجل. ويتضمن ذلك شركة Cenomi Centers، المالكة والمشغلة والمطورة لمراكز التسوق في المملكة العربية السعودية.


 لقد خصصت I Squared مبلغ 150 مليون دولار أمريكي1 لدعم نمو Radiant، واضعة نصب أعينها هدف توفير أكثر من 1 جيجاواط من حلول الطاقة المتجددة الملحقة بمواقع الاستهلاك، والتخزين، وغيرها من حلول تحول الطاقة في كل أنحاء دول مجلس التعاون الخليجي (GCC). وتجدر هنا الإشارة إلى أنَّ هذا الاستثمار الفاعل يرتقي بمنصة Radiant إلى مصاف المنصات الرائدة في تطوير حلول إزالة الكربون في المملكة العربية السعودية، إذ يجمع بين فريق إدارة محلي محنك وخبرة I Squared العالمية في بناء المنصات، على أن تنضم منصة Radiant إلى محفظة I Squared المتنامية من الاستثمارات العالمية في مجال الطاقة المتجددة، والتي تشمل أكثر من 10,000 ميجاواط من القدرة المتجددة.


صرح صادق وهبة، رئيس مجلس الإدارة والشريك الإداري في I Squared Capital، قائلاً: "يُعدّ الشرق الأوسط أحد أكثر أسواق البنية التحتية ديناميكية على مستوى العالم، مدعومًا بنمو اقتصادي قوي، وأجندة طموحة لتحول الطاقة، والتزام واضح بإشراك القطاع الخاص".


صرح Harsh Agrawal، الشريك الأول في I Squared Capital، قائلاً: "يمثل إطلاق Radiant Energy Solutions محطة مهمة في مسيرة I Squared، كما يعكس قناعتنا الراسخة بالأسس طويلة الأجل في المنطقة، وتحت مظلة Radiant، نعمل على نقل خبرة I Squared العالمية في مجال الطاقة لدعم تحول دول الخليج نحو أنظمة طاقة أكثر كفاءة ومرونة واستدامة".


ترتكز إستراتيجية Radiant على الطلب متزايد الوتيرة على حلول الطاقة الموزعة في دول مجلس التعاون الخليجي، وذلك في ظل السياسات الداعمة، وارتفاع معدل استهلاك الكهرباء، وزيادة تركيز العملاء من القطاعين التجاري والصناعي على خفض التكاليف وتعزيز مبادئ الاستدامة. وقد تم تصميم المنصة بحيث يمكنها قطع خطوات واثقة على طريق التوسع ذاتيًا أو عن طريق صفقات الاستحواذ، مقدمة تقنيات الطاقة الشمسية، والتخزين، وغيرها من تقنيات تحول الطاقة، بما يتوافق مع احتياجات الأسواق الإقليمية.


يأتي إطلاق Radiant تعزيزًا للحضور الراسخ والمتنامي لشركة I Squared في الشرق الأوسط، المدعوم بمكتبها في أبو ظبي وخططها لافتتاح مكتب في الرياض. وفي عام 2025، عززت I Squared مشاركتها على الصعيد الإقليمي تعزيزًا هائلاً، وذلك عن طريق توقيع مذكرات تفاهم مع The Arab Energy Fund (TAEF) وPublic Investment Fund (PIF)، في خطوة تعكس الطموح المشترك الرامي إلى تسريع تطوير البنية التحتية المستدامة في المنطقة.


 نبذة عن I Squared Capital


 تُعدّ I Squared Capital شركة استثمارية رائدة عالميًا في مجال تطوير البنية التحتية تدير أصولاً بقيمة 50 مليار دولار أمريكي، فنحن نعمل على بناء وتوسيع شركات البنية التحتية الأساسية التي تقدم خدمات حيوية لملايين الأشخاص على مستوى العالم. ثم إنَّ محفظة I Squared تضم أكثر من 96 شركة فاعلة في أكثر من 70 دولة، وتشمل قطاعات، مثل الطاقة، والمرافق العامة، والبنية التحتية الرقمية، والنقل، والبنية التحتية البيئية والاجتماعية. هذا، ويقع المقر الرئيسي للشركة في ميامي، وتضم بين جنباتها فريقًا قوامه أكثر من 300 متخصص فاعل في مكاتبها في أبو ظبي ولندن وميونيخ ونيو دلهي وساو باولو وسنغافورة وسيدني وتايبيه. تعرّف على المزيد على www.isquaredcapital.com.


 إخلاء مسؤولية


 لا يُعدّ هذا المستند نصيحة أو توصية، ولا عرضًا للبيع، ولا دعوة للتعامل بأي أوراق مالية أو منتجات مالية، إذ يقتصر الغرض منه على توفير معلومات فحسب. جدير بالبيان أنَّ الاستثمار ينطوي على مخاطر، وثمة احتمالية لخسارة رأس المال. كما أنَّ الاستثمارات المحددة الموضحة في هذا المستند لا تمثل كافة القرارات الاستثمارية التي اتخذتها شركة ISQ. هذا، ولا ينبغي للقارئ افتراض أنَّ القرارات الاستثمارية التي تم تحديدها ومناقشتها كانت أو ستكون مربحة. وأخيرًا وليس آخرًا، فالتوصيات الاستثمارية المحددة الواردة هنا هي لأغراض توضيحية فحسب، ولا تمثل بالضرورة الاستثمارات التي ستُجرى في المستقبل.


____________________


1 يمثل المبلغ رأس مال مخصصًا، خاضعًا للشروط والأحكام


 


إن نص اللغة الأصلية لهذا البيان هو النسخة الرسمية المعتمدة. أما الترجمة فقد قدمت للمساعدة فقط، ويجب الرجوع لنص اللغة الأصلية الذي يمثل النسخة الوحيدة ذات التأثير القانوني.



الرابط الثابت

https://aetoswire.com/ar/news/2301202652618


جهات الاتصال

 جهة الاتصال الإعلامية:

 I Squared Capital

 Sofie Brewis

 info@isquaredcapital.com 

I Squared Announces Launch of Radiant Energy Solutions

 


(BUSINESS WIRE)--I Squared Capital (“I Squared”), a leading global infrastructure investment manager, announced today the launch of Radiant Energy Solutions (“Radiant”), an investment from I Squared’s Middle East infrastructure strategy, which is focused on targeting transformational, mid-market investments in the region.


Reflecting I Squared’s platform-building approach of starting with a core initial investment and scaling over time to build market-leading businesses, Radiant marks the firm’s entry into the Middle East distributed renewables market, providing decarbonization solutions to commercial and industrial customers. The investment for Radiant is the acquisition of FAS Renewables and its 100% owned subsidiary Zahra Energy, a Saudi Arabia–based distributed solar company with a secured and advanced portfolio of over 100MWp of distributed solar projects with established customers and long-term contracted solar power purchase agreements. These include Cenomi Centers, an owner, operator, and developer of shopping centers in Saudi Arabia.


I Squared has committed US$150 million1 to support Radiant’s growth, with the ambition to deliver more than 1GW of behind-the-meter renewable energy, storage, and other energy transition solutions across the Gulf Cooperation Council (“GCC”). This investment positions Radiant as one of the leading developers of decarbonization solutions in Saudi Arabia and brings together an experienced local management team with I Squared’s global platform-building expertise. The Radiant platform joins I Squared’s growing portfolio of global renewable energy investments, which includes more than 10,000 MW of renewable capacity.


Sadek Wahba, Chairman and Managing Partner, I Squared Capital said: “The Middle East is one of the most dynamic infrastructure markets globally, underpinned by strong economic growth, an ambitious energy transition agenda, and a clear commitment to private sector participation.”


Harsh Agrawal, Senior Partner, I Squared Capital, said: “The launch of Radiant Energy Solutions represents an important milestone for I Squared and reflects our conviction in the region’s long-term fundamentals. Through Radiant, we are bringing I Squared’s global energy expertise to support the Gulf’s transition toward more efficient, resilient, and sustainable energy systems.”


Radiant’s strategy is anchored in the rapidly growing demand for distributed energy solutions across the GCC, driven by policy tailwinds, rising power consumption, and the increasing focus of commercial and industrial customers on cost savings and sustainability. The platform is designed to scale organically and through acquisitions, offering solar, storage, and other energy transition technologies tailored to regional market needs.


The launch of Radiant builds on I Squared’s established and growing presence in the Middle East supported by its office in Abu Dhabi and the planned opening of its office in Riyadh. In 2025, I Squared further deepened its regional engagement by signing memorandums of understanding with The Arab Energy Fund (“TAEF”) and the Public Investment Fund (“PIF”), underscoring a shared ambition to accelerate sustainable infrastructure across the region.


About I Squared Capital


I Squared Capital is a leading global infrastructure investor managing $50 billion in assets. We build and scale essential infrastructure businesses that deliver critical services to millions of people worldwide. The I Squared portfolio includes over 96 companies operating in more than 70 countries and spanning sectors such as energy, utilities, digital infrastructure, transport, environmental and social infrastructure. Headquartered in Miami, its team of over 300 professionals is based across offices in Abu Dhabi, London, Munich, New Delhi, São Paulo, Singapore, Sydney and Taipei. Learn more at www.isquaredcapital.com.


Disclaimers


This document does not constitute advice or a recommendation or offer to sell or a solicitation to deal in any security or financial product. It is provided for information purposes only. Investing involves risk, loss of principal is possible. Specific investments described herein do not represent all investment decisions made by ISQ. The reader should not assume that investment decisions identified and discussed were or will be profitable. Specific investment advice references provided herein are for illustrative purposes only and are not necessarily representative of investments that will be made in the future.


____________________


1 Represents earmarked capital, subject to terms and conditions


 


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260121714056/en/



Permalink

https://aetoswire.com/en/news/2201202652535


Contacts

Media:

I Squared Capital

Sofie Brewis

info@isquaredcapital.com

أطلقت شركة سنترال باتانا، بالتعاون مع هيئة السياحة التايلاندية وشركة والت ديزني (تايلاند)، فعالية "أرض الاحتفالات السحرية" في تايلاند: تجربة عيد ميلاد مستوحاة من ديزني


تعاونت شركة سنترال باتانا (Central Pattana plc)، الرائدة في مجال التطوير العقاري المستدام في تايلاند، والمشغلة لمراكز تسوق سنترال في جميع أنحاء البلاد، مع هيئة السياحة التايلاندية وشركة والت ديزني (تايلاند) لاستثمار أكثر من 800 مليون بات تايلاندي في فعالية "النجوم السحرية" (The Magical Stars) التي تُعدّ حدثًا عالميًا مميزًا للاحتفال بنهاية العام. وقدّمت الحملة أربع عوالم خيالية مستوحاة من ديزني، أبرزها شجرة عيد الميلاد المميزة وتمثالان ضخمان لميكي ماوس وميني ماوس بارتفاع 3 أمتار يرتديان الحرير التايلاندي، وذلك في فعالية "النجوم السحرية 2026" في سنترال وورلد، بالإضافة إلى مدينة السحر المستوحاة من ميكي وأصدقائه، وقلعة السحر المستوحاة من أميرات ديزني.


 


هدفت المبادرة إلى تحفيز اقتصاد تايلاند وقطاع السياحة فيها من خلال استراتيجية "اقتصاد المهرجانات"، التي ربطت السعادة في جميع مراكز سنترال (Central) للتسوق في أنحاء البلاد، بما في ذلك تلك الموجودة في أهم الوجهات السياحية مثل سنترال وورلد بانكوك (centralwOrld Bangkok)، وسنترال فوكيت (Central Phuket)، وسنترال باتايا (Central Pattaya)، وسنترال شيانغ ماي (Central Chiangmai)، وغيرها الكثير. وقد جلبت "النجوم السحرية" بهجة احتفالية من 14 نوفمبر 2025 إلى 11 يناير 2026.


 


كما عرضت سنترال باتايا جمال الفن والثقافة التايلانديين من خلال "فخر تايلاند السحري" (The Magical Thai Pride)، وهي أشجار عيد الميلاد التي تحمل رموزًا تايلاندية، والتي صنعتها المجتمعات المحلية في جميع أنحاء البلاد تكريمًا لجلالة الملكة سيريكيت، الملكة الأم، واستمرارًا لإرثها في الارتقاء بالحرف اليدوية التايلاندية على الساحة العالمية.


 


في هذه الحملة، تعاونت سنترال مع شركاء رائدين، من بينهم هيئة السياحة في تايلاند، وذا والت ديزني تايلاند، وبطاقة سنترال ذا ون الائتمانية (Central The1 Credit Card)، وخدمات البطاقات العامة (General Card Services)، وإيون ثانا سينساب (AEON Thana Sinsap)، وبنك بانكوك، وكارد إكس (Card X)، وبنك سيام التجاري، وبنك الادخار الحكومي، وبنك كاسيكورن  Kasikorn Bank)، وبطاقة كرونغسري أيوديا (Krungsri Ayudhya Card)، وبنك كرونغتاي (Krungthai Bank)، وبطاقة كرونغتاي (Krungthai Card)، وبطاقة ائتمان تي تي بي (TTB Credit Card): (بطاقة ائتمان تي إم بي  TMB، وبطاقة ائتمان ثاناتشارت Thanachart ، وبطاقة ائتمان يو أو بي  UOB).


 


وقدّمت سنترال وورلد هذا الموسم أكبر تجربة ديزني في آسيا، على مساحة تزيد عن 3500 متر مربع. أحيت فعالية ديزني ذا ماجيكال ستارز 2026 سبع مناطق تفاعلية، من بينها مشهد شتوي لميكي وأصدقائه، وتوي ستوري، وزوتوبيا، وستيتش، وفروزن، وقلعة أميرة فخمة، وتكريم خاص للذكرى العشرين لديزني لاند هونغ كونغ، حيث ضمت مجسمًا قابلًا للنفخ لميكي بطول 5 أمتار يرتدي زيًا محدود الإصدار، وقوسًا مُقلّدًا. امتد الاحتفال ليشمل 24 مركزًا تجاريًا تابعًا لسلسلة سنترال، حيث استمتع الزوار بأجواء مدينة السحر مع شخصيات ميكي وأصدقائه في احتفالات بهيجة.


 


وتمتع المتسوقون في جميع فروع سنترال بمزايا احتفالية خاصة. كما حصل المسافرون الدوليون الذين أنفقوا 6000 بات تايلندي أو أكثر على حقيبة تسوق من جود جودز (Good Goods).



الرابط الثابت

https://aetoswire.com/ar/news/2201202652551


جهات الاتصال

ريبيكا ترافاسو


rebecca@mediarepublic.biz 

Central Pattana, TAT and The Walt Disney (Thailand) Launched Magical Festivities Land in Thailand: Disney-Themed Christmas Experience

 


Central Pattana plc, Thailand’s leading sustainable real estate developer and operator of Central shopping centers nationwide, joined forces with the Tourism Authority of Thailand (TAT) and The Walt Disney (Thailand) to invest over 800 million baht in creating a global year-end festive sensation with ‘The Magical Stars’. The campaign introduced four Disney-themed fairytale kingdoms, highlighted by a signature Christmas tree and 3-meter-tall Mickey Mouse and Minnie Mouse dressed in Thai silk at Disney The Magical Stars 2026 at centralwOrld, along with Magic Town, featuring a Mickey & Friends theme, and Magic Castle, inspired by Disney Princesses. The initiative aimed to stimulate Thailand’s economy and tourism through a ‘Festival Economy’ strategy, connecting happiness across Central shopping centers nationwide, including Central shopping centres in top tourist destinations such as centralwOrld Bangkok, Central Phuket, Central Pattaya, Central Chiangmai and many more. The Magical Stars brought festive joy from 14 November 2025 to 11 January 2026.


Central Pattana also showcased the beauty of Thai art and culture through ‘The Magical Thai Pride’, the Christmas trees with Thai identities, crafted by communities nationwide to honor Her Majesty Queen Sirikit, the Queen Mother, and to continue her legacy of elevating Thai handicrafts on the global stage.


In this campaign, Central joined hands with leading partners including the Tourism Authority of Thailand, The Walt Disney Thailand, Central The1 Credit Card, General Card Services, AEON Thana Sinsap, Bangkok Bank, Card X, Siam Commercial Bank, Government Savings Bank, Kasikorn Bank, Krungsri Ayudhya Card, Krungthai Bank, Krungthai Card, TTB Credit Card (TMB Credit Card, Thanachart Credit Card and UOB Credit Card).


This season, centralwOrld presented the largest Disney experience in Asia, spanning over 3,500 sqm. Disney The Magical Stars 2026 brought seven immersive zones to life, including a Mickey & Friends winter scene, Toy Story, Zootopia, Stitch, Frozen, a grand Princess Castle, and a special tribute to the 20th anniversary of Hong Kong Disneyland, featuring a 5-meter inflatable Mickey in a limited-edition costume and replica archway. The celebration extended to 24 Central shopping centers, where visitors enjoyed the Magic Town theme with Mickey & Friends in joyful holiday settings.


Across Central locations, shoppers enjoyed special festive privileges. International travelers who spent THB 6,000 or more received a Good Goods Tote Bag.



Permalink

https://aetoswire.com/en/news/2201202652549


Contacts

Rebecca Travasso


rebecca@mediarepublic.biz

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

ZUG, Switzerland - Thursday, 22. January 2026

  • At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas1-7
  • Multiple studies will reinforce the safety and efficacy of Galderma’s hyaluronic acid (HA) treatments range, including post-marketing data on Restylane® Shaype™ in shaping the chin, Restylane Lyft™ in improving jawline definition, Restylane Skinboosters™ in smoothing fine lines and wrinkles in the décolletage and Restylane Volyme™ in correcting hollowing of the temples8-11
  • New data on the innovative neuromodulator Relfydess™ (RelabotulinumtoxinA) will reinforce its rapid onset as early as Day 1 and sustained efficacy through six months for frown lines and crow’s feet12
  • As a leader in injectable aesthetic innovation, Galderma will showcase its superior science and educational capabilities at the congress

 

(BUSINESS WIRE) -- Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The company will also showcase its leadership in community education through a number of events including two symposia, a live anatomy workshop, multiple masterclasses and meet-the-expert sessions, and a booth that will delve into the science behind its innovations.

“With ten posters spanning all key aesthetic treatment modalities and areas across the face and body, our data at IMCAS truly showcases the breadth and versatility of our injectable aesthetics portfolio and how we continue to drive innovation with our trusted products. In tandem with our first-class Galderma Aesthetic Injector Network (GAIN) educational activities, conducted in partnership with renowned experts, we are equipping practitioners with all the tools they need to take a personalized and holistic approach to treatment.”

BILL ANDRIOPOULOS, PH.D.

HEAD OF GLOBAL MEDICAL AFFAIRS

GALDERMA

 

Biostimulation: Sculptra’s innovative approach to regenerative aesthetics for the face and body backed by experts
In response to patients increasingly seeking harmony between facial and body aesthetics, Galderma recently announced the EU MDR certification of Sculptra, the first proven regenerative biostimulator, expanding its current clinical use to the body.3 At IMCAS, guidance developed by 13 international experts on Sculptra’s four MDR-approved indications – the gluteal area, posterior thighs, décolletage, and upper arms – will be presented.1 The experts concluded that Sculptra’s benefits can be complemented with Restylane Skinboosters in the décolletage for comprehensive body rejuvenation, and recommended injection volumes for Sculptra to be used in the posterior thighs, upper arms and gluteal area to improve aesthetic appearance, including skin firmness and reduced appearance of cellulite.1

Results from an expert review of data on Sculptra will also be presented, providing additional evidence of its regenerative properties.2 This includes fibroblast activation leading to stimulation of collagen, elastin and other proteins involved in extracellular matrix regeneration and adipogenesis (the formation of healthy fat cells).2 This clinically presents as long-term improvements such as increased volume, elasticity, and skin thickness.2

A final poster will examine the ease of Sculptra’s reconstitution process compared with two other poly-L-lactic acid biostimulators, finding that healthcare professionals had a strong preference for Sculptra’s reconstitution process and positively rated its speed of administration from preparation to injection.13

HA treatments: The Restylane range demonstrates its versatility in meeting diverse patient needs
Data from across Galderma’s portfolio of Restylane HA treatments will be presented supporting its versatile use on the face and décolletage, with a range of gel formulations to meet personalized needs from providing structural support to smoothing lines and wrinkles:

  • The ARTIST post-marketing study found that Restylane Shaype, powered by new NASHA HD™ technology, is a safe and effective treatment for shaping the chin with natural-looking results, alone or in combination with Restylane Defyne™ and Restylane Lyft to provide lift, shape, and definition for diverse aesthetic needs.8 The poster also supports that Restylane Shaype has the highest G-prime (a measure of firmness) compared with other HA treatments produced with different manufacturing technologies, allowing for greater correction with lower injection volumes.8

  • A study of Restylane Lyft for jawline definition showed it was effective and safe, and resulted in high subject satisfaction and aesthetic improvement through 12 months.9

  • A study evaluating the effectiveness and safety of Restylane Skinboosters for correction of moderate-to-severe wrinkles in the décolletage found that it was well tolerated and highly efficacious with a significant improvement through Week 32 and high patient satisfaction.10

  • A study of Restylane Volyme showed that it was safe and effective for correction of temple hollowing, with high and sustained results through Month 18 and high patient satisfaction.11

Neuromodulation: Supporting Relfydess’ next-generation performance
Results will be presented from an analysis of wrinkle morphology and dynamic skin strain in the RELAX and EXPRESSION trials investigating Relfydess – the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology.12,14 Results reinforce its onset of action as early as Day 1 in patients with moderate-to-severe frown lines and crow’s feet, with sustained improvements for six months.12 Expert-led consensus recommendations will also be shared addressing important unmet needs in real-world clinical practice and providing clear guidance for the practical use of Relfydess, helping healthcare professionals select the optimal treatment protocol for their patients.15

Spearheading community education and awareness around unmet patient needs
Galderma will also present findings from a global survey of over 4,300 women across five continents linking menopause to several skin changes, including wrinkles, loss of firmness, dryness and dull skin, and the potential role of aesthetic treatments to address them.16,17 As part of its response to this, Galderma will host a symposium titled ‘Menopause in the Mirror: Challenges, Science and Aesthetic Solutions’ on Friday, January 30 at 10:30 AM – 12:30 PM CET in Grand Amphi - Level 1.

A second symposium, titled ‘Exploring Breakthroughs in Injectable Regeneration for the Face, Body, and Skin Health’ will delve into the growing demand for holistic regenerative aesthetic solutions and take place on Thursday January 29 at 1:30 – 2:30 PM CET in Room 251, Level 2.

More information about Galderma’s activities at IMCAS 2026 can be found here.

About Sculptra
Sculptra is the first proven regenerative biostimulator, with a unique poly-L-lactic acid (PLLA-SCA™) formulation, to provide progressive and sustained regenerative effect across all three skin layers.3,18-24 Sculptra reverses aging processes in the skin, including degradation of the extracellular matrix, which results in volume loss, laxity, and the appearance of wrinkles.3,18,19,25-27 Sculptra progressively rebuilds the skin’s structural foundation by encouraging the remodeling of components of the extracellular matrix, such as elastin and collagen, helping to gradually restore volume, firmness, radiance and skin quality, and the look of fullness to wrinkles and folds over time.3-7,18,19,28 Sculptra has been shown to provide visible improvements as early as one month after treatment, with results lasting up to two years.3,6,23,28,29

About the Restylane portfolio
Restylane HA treatments are designed differently to go beyond volumizing for natural-looking results.30-33 Our HA is minimally modified and our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose.34-37 Powered by NASHA®, NASHA HD, OBT™ and SB-NASHA™ technologies, Restylane offers gels with the highest firmness to the highest flexibility, enabling personalized treatments that deliver structural support, natural-looking results, and a healthy glow.38-41 Trusted for almost three decades, our HA gels work in sync with your skin for 100% natural-looking results.30,42,43

About Relfydess (RelabotulinumtoxinA)
Pioneered by Galderma, Relfydess is the first and only ready-to-use liquid neuromodulator created with PEARL Technology that is designed to preserve molecule integrity.14 PEARL Technology is designed to deliver a highly active, innovative, complex-free molecule, with up to 39% of patients seeing effects from day one and up to 75% of patients maintaining improvements for six months.14,44,45 Relfydess is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.46,47 It was entirely created and manufactured by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market. Relfydess received a marketing authorization in several markets. RelabotulinumtoxinA is an investigational drug product in the U.S. Authorization conditions may vary internationally.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

  1. Haddad A, et al. International consensus: Sculptra®/Restylane® Skinboosters™ for non-facial rejuvenation. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  2. Fabi SG, et al. Regenerative aesthetic effects of poly L-lactic acid treatment. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  3. Sculptra®. EU Instructions for Use. 2025. Available online. Accessed January 2026.

  4. Galderma. Data on File. MA-57540.

  5. Nikolis A, et al. A Prospective, Multicenter Trial on the Efficacy and Safety of Poly-L-Lactic Acid for the Treatment of Contour Deformities of the Buttock Regions. J Drugs Dermatol. 2022;21(3):295–303. doi: 10.36849/JDD.5924.

  6. Beleznay K, et al. Safety and Effectiveness of Poly-L-lactic acid (PLLA-SCA) for the Improvement in Appearance of Cellulite – A Pilot Study. Poster presented at the IMCAS World Congress; February 1-3, 2024; Paris, France.

  7. Mazzuco R, et al. Clinical and Histological comparative outcomes after injections of Poly-L-Lactic Acid and Calcium Hydroxyapatite in arms – a split side study. J Cosmet Dermatol. 2022;21(12):6727–6733. doi: 10.1111/jocd.15356. Epub 2022 Sep 20.

  8. Nikolis A, et al. A new NASHA-HD, high G’ hyaluronic acid (HA) injectable evaluated for chin treatment in combination with lower face and mid-face HA filler treatment. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  9. Rivers J, et al. Effectiveness and safety of Restylane® Lyft™ Lidocaine for jaw-line definition: A 12-month randomized controlled study. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  10. Moradi A, et al. Effectiveness and safety of a hyaluronic acid skin quality injectable for the correction of wrinkles in the décolletage area. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  11. Nestor M. Safety and effectiveness of an OBT™ hyaluronic acid filler for temple hollowing treatment: a randomized, controlled, clinical investigation. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  12. Moradi A, et al. Objective image analysis of wrinkle morphology and dynamic skin strain in GLs and LCLs treated with relaBoNT-A in the RELAX and EXPRESSION trials. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  13. Nikolis A, et al. Preferences and experiences across biostimulatory poly-L-lactic acid’s reconstitution processes and injection criteria (PREP study). Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  14. Shridharani SM, et al. Efficacy and safety of RelabotulinumtoxinA, a new ready-to-use liquid formulation botulinum toxin: Results from the READY-1 double-blind, randomized, placebo-controlled phase 3 trial in glabellar lines. Aesthet Surg J. 2024;44(12):1330-1340. doi: 10.1093/asj/sjae131.

  15. Ascher B, et al. Consensus Recommendations on the Aesthetic Use of RelabotulinumtoxinA to Treat Upper Face Wrinkles. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  16. Fabi SG, et al. The potential role of biostimulators/dermal fillers to address menopause-related skin conditions. Poster presented at IMCAS 2026; January 29-31, 2026; Paris, France.

  17. Galderma. Data on file. Menopause Patient Survey.

  18. Waibel J, et al. Bulk RNA-seq Analysis of Poly-L-Lactic Acid (PLLA-SCA) vs Calcium Hydroxyapatite (CaHA-R) Reveals a Novel, Adipocyte Mediated Regenerative Mechanism of Action Unique to PLLA. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.

  19. Waibel J, et al. Gene Analysis of Biostimulators: PLLA-SCA Triggers Regenerative Morphogenesis while CaHA-R Induces Inflammation upon Facial Injection. Poster presented at ASDS 2024 Annual Meeting; October 17-20, 2024; Orlando, Florida, United States.

  20. Huth S, et al. Molecular Insights into the effects of PLLA_SCA on Gene Expression and Collagen Synthesis in Human 3D Skin Models Containing Macrophages. J Drugs Dermatol. 2024;23(4):285–288. doi: 10.36849/JDD.7791.

  21. Galderma. Data on File. MA-46589.

  22. Vleggaar D, et al. Consensus recommendations on the use of injectable poly-L-lactic-acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44–s51.

  23. Widgegrow J, et al. A randomized, comparative study describing the gene signatures of poly-l-lactic acid (PLLA-SCA) and Calcium Hydroxyapatite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 1-3, 2024. Paris, France.

  24. Duracinsky M, et al. Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infect Dis. 2014;14(474). doi: 10.1186/1471-2334-14-474.

  25. Zhang S and Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018;27(5):729–738. doi: 10.1177/0963689717725755.

  26. Shuster S, et al. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-43. doi: 10.1111/j.1365-2133.1975.tb05113.x.

  27. Zarbafian M, et al. The emerging field of regenerative aesthetics—where we are now. Dermatol Surg. 2022;48:101–108. doi: 10.1097/DSS.0000000000003239.

  28. Fabi S, et al. 24-month clinical trial data on effectiveness and safety after correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant. Poster presented at IMCAS World Congress; January 26-28, 2023; Paris, France.

  29. Goldberg D, et al. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915–922. doi: 10.1111/dsu.12164.

  30. Di Gregorio C, et al. 25+ years of experience with the Restylane portfolio of injectable HA fillers for facial aesthetic treatment. E-poster presented at AMWC; March 27-29, 2024; Monaco.

  31. Nikolis A, et al. The role of clinical examination in midface volume correction using hyaluronic acid fillers: should patients be stratified by skin thickness? Aesthet Surg J Open Forum. 2020;2(1):1–12. doi: 10.1093/asjof/ojaa005.

  32. Talarico S, et al. High patient satisfaction of a HA filler producing enduring full-facial volume restoration: an 18- month open multicenter study. Dermatol Surg. 2015;41:1361–1369. doi: 10.1097/DSS.0000000000000549.

  33. Restylane. U.S. Instructions for use. Available online. Accessed January 2026.

  34. Edsman K, et al. Gel properties of hyaluronic acid dermal fillers. Dermatol Surg. 2012;38:1170–1179. doi: 10.1111/j.1524-4725.2012.02472.x.

  35. Galderma. Data on file. MA-58650. Degree of modification of HA fillers.

  36. Seo K. Facial volumization with fillers. Springer. 2021;29–83. https://doi.org/10.1007/978-981-33-6212-3_2.

  37. Kablik J, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009:35S(1):302–312. doi: 10.1111/j.1524-4725.2008.01046.x.

  38. Galderma Data on file. MA-56724. X-strain and G’ including Shaype.

  39. Nikolis A, et al. Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion. J Drugs Dermatol. 2024;23(4):255–261. doi: 10.36849/JDD.8145.

  40. Öhrlund Å et al. Differentiation of NASHA and OBT Hyaluronic Acid Gels According to Strength, Flexibility, and Associated Clinical Significance J Drugs Dermatol. 2024;23(1):1332–1336. doi: 10.36849/JDD.7648.

  41. Belmontesi M et al. Injectable Non-Animal Stabilized Hyaluronic Acid as a Skin Quality Booster: An Expert Panel Consensus J Drugs Dermatol. 2018;17(1):83–88.

  42. Solish N, et al. Dynamics of HA fillers formulated to maintain natural facial expression. J Cosmet Dermatol. 2019;18(3):738-746. doi: 10.1111/jocd.12961.

  43. Philipp‐Dormston WG, et al. Perceived naturalness of facial expression after HA filler injection in nasolabial folds and lower face. J Cosmet Dermatol. 2020;19(7):1600-1606. doi: 10.1111/jocd.13205.

  44. Ablon G, et al. Treatment of lateral canthal lines with RelabotulinumtoxinA, an investigational liquid botulinum toxin: clinical efficacy and safety results from the READY-2 phase 3 trial. Toxicon. 2024;237(1):107353. doi: 10.1026/j.toxicon.2024.107353.

  45. Relfydess®. EU Summary of Product Characteristics.

  46. Sundberg AL and Stahl U. Relabotulinum toxin - a novel, high purity BoNT-A1 in liquid formulation. Presented at TOXINS; January 16-17, 2021; virtual meeting.

  47. Do M, et al. Purification process of a complex-free highly purified botulinum neurotoxin type A1 (BoNT-A1) - relabotulinumtoxinA. Presented at TOXINS; July 27-30, 2022; Louisiana, United States.

 

 



Contacts

For further information:

Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87

Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43